262 related articles for article (PubMed ID: 28289191)
1. Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.
Ainscough JS; Macleod T; McGonagle D; Brakefield R; Baron JM; Alase A; Wittmann M; Stacey M
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2748-E2757. PubMed ID: 28289191
[TBL] [Abstract][Full Text] [Related]
2. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis.
Guo J; Tu J; Hu Y; Song G; Yin Z
Drug Des Devel Ther; 2019; 13():581-588. PubMed ID: 30804664
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines.
Henry CM; Sullivan GP; Clancy DM; Afonina IS; Kulms D; Martin SJ
Cell Rep; 2016 Feb; 14(4):708-722. PubMed ID: 26776523
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of interleukin 36γ and its cleaver cathepsin G following treatment with narrow-band ultraviolet B phototherapy in psoriasis vulgaris.
El-Kalioby M; El-Komy MHM; Said ER; Amer MA; Saadi DG; Nouredin Mohammed F; Rashed LA; El Desouky ED; AlOrbani AM
J Dermatolog Treat; 2022 Jun; 33(4):2358-2363. PubMed ID: 34376113
[TBL] [Abstract][Full Text] [Related]
7. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation.
Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N
Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571
[TBL] [Abstract][Full Text] [Related]
8. IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis.
Wang W; Yu X; Wu C; Jin H
Int J Med Sci; 2017; 14(10):1002-1007. PubMed ID: 28924372
[TBL] [Abstract][Full Text] [Related]
9. IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.
Bridgewood C; Fearnley GW; Berekmeri A; Laws P; Macleod T; Ponnambalam S; Stacey M; Graham A; Wittmann M
Front Immunol; 2018; 9():200. PubMed ID: 29535706
[TBL] [Abstract][Full Text] [Related]
10. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes.
Li N; Yamasaki K; Saito R; Fukushi-Takahashi S; Shimada-Omori R; Asano M; Aiba S
J Immunol; 2014 Nov; 193(10):5140-8. PubMed ID: 25305315
[TBL] [Abstract][Full Text] [Related]
11. The Proinflammatory Cytokine IL-36γ Is a Global Discriminator of Harmless Microbes and Invasive Pathogens within Epithelial Tissues.
Macleod T; Ainscough JS; Hesse C; Konzok S; Braun A; Buhl AL; Wenzel J; Bowyer P; Terao Y; Herrick S; Wittmann M; Stacey M
Cell Rep; 2020 Dec; 33(11):108515. PubMed ID: 33326792
[TBL] [Abstract][Full Text] [Related]
12. IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions.
D'Erme AM; Wilsmann-Theis D; Wagenpfeil J; Hölzel M; Ferring-Schmitt S; Sternberg S; Wittmann M; Peters B; Bosio A; Bieber T; Wenzel J
J Invest Dermatol; 2015 Apr; 135(4):1025-1032. PubMed ID: 25525775
[TBL] [Abstract][Full Text] [Related]
13. Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases.
Sullivan GP; Henry CM; Clancy DM; Mametnabiev T; Belotcerkovskaya E; Davidovich P; Sura-Trueba S; Garabadzhiu AV; Martin SJ
Cell Death Dis; 2018 Mar; 9(3):378. PubMed ID: 29515113
[TBL] [Abstract][Full Text] [Related]
14. The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.
Pfaff CM; Marquardt Y; Fietkau K; Baron JM; Lüscher B
Sci Rep; 2017 Nov; 7(1):15631. PubMed ID: 29142248
[TBL] [Abstract][Full Text] [Related]
15. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
[TBL] [Abstract][Full Text] [Related]
16. The role of IL-36γ and its regulation in eosinophilic inflammation in allergic rhinitis.
Qin X; Liu M; Zhang S; Wang C; Zhang T
Cytokine; 2019 May; 117():84-90. PubMed ID: 30831444
[TBL] [Abstract][Full Text] [Related]
17. Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis.
Todorović V; Su Z; Putman CB; Kakavas SJ; Salte KM; McDonald HA; Wetter JB; Paulsboe SE; Sun Q; Gerstein CE; Medina L; Sielaff B; Sadhukhan R; Stockmann H; Richardson PL; Qiu W; Argiriadi MA; Henry RF; Herold JM; Shotwell JB; McGaraughty SP; Honore P; Gopalakrishnan SM; Sun CC; Scott VE
Sci Rep; 2019 Jun; 9(1):9089. PubMed ID: 31235749
[TBL] [Abstract][Full Text] [Related]
18. IL-36γ Induced by the TLR3-SLUG-VDR Axis Promotes Wound Healing via REG3A.
Jiang Z; Liu Y; Li C; Chang L; Wang W; Wang Z; Gao X; Ryffel B; Wu Y; Lai Y
J Invest Dermatol; 2017 Dec; 137(12):2620-2629. PubMed ID: 28774595
[TBL] [Abstract][Full Text] [Related]
19. Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation.
Sullivan GP; Davidovich PB; Sura-Trueba S; Belotcerkovskaya E; Henry CM; Clancy DM; Zinoveva A; Mametnabiev T; Garabadzhiu AV; Martin SJ
FEBS Open Bio; 2018 May; 8(5):751-763. PubMed ID: 29744290
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the Peptidoglycan Amidase PGLYRP2 in Epithelial Cells by Interleukin-36γ.
Scholz GM; Heath JE; Aw J; Reynolds EC
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29914927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
